Abstract:Background: Lung cancer is the most common primary malignant tumor of the lung, and as one of the malignant tumors that pose the greatest threat to the health of the population, the incidence rate has remained high in recent years. Previous studies have shown that KLRB1 is transcriptionally repressed in lung adenocarcinoma and correlates with lung adenocarcinoma prognosis. The objective of this study is to investigate the intrinsic mechanisms by which KLRB1 affects the malignant phenotypes of lung adenocarcinoma such as immune infiltration, proliferation, growth and metastasis. Methods: We assessed the expression levels of KLRB1 in publicly available databases and investigated its associations with clinical and pathological variables. Enrichment analysis was subsequently conducted to investigate possible signaling pathways and their associated biological functions. Statistical analysis, including Spearman correlation and the application of multigene prediction models, was utilized to assess the relationship between the expression of KLRB1 and the infiltration of immune cells. The diagnostic and prognostic value of KLRB1 was evaluated using Kaplan-Meier survival curves, diagnostic receptor operating characteristic (ROC) curves, histogram models, and Cox regression analysis. Specimens from lung adenocarcinoma (LUAD) patients were collected, the expression level of KLRB1 was detected by protein blotting analysis, and the expression level of KLRB1 was detected at the mRNA level by real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR). Small interfering RNA (siRNA) was used to silence gene expression, and Transwell, Cell Counting Kit-8 (CCK-8) and colony formation assays were subsequently performed to analyze the effects of KLRB1 on LUAD cell migration, invasion and proliferation. Results: KLRB1 expression was lower in lung cancer tissue than in surrounding healthy tissue. Genes differentially expressed in the low and high KLRB1 expression groups were found to be significantly enriched in pathways related to immunity. KLRB1 exerted an impact on the MAPK/ERK signaling pathway, thereby modulating the growth and proliferation of LUAD cells. KLRB1 expression is linked to prognosis, immune infiltration, and cell migration and proliferation in LUAD. Conclusions: The evidence revealed a correlation between KLRB1 and both prognosis and immune infiltration in LUAD patients.

Roles of EGFR and RAS/MAPK Signal Transduction Pathway Activated Protein ERK1/2in Lung Cancer

Expression of EGFR and RAS/MAPK signal pathway-related proteins and their significance in lung adenocarcinoma

Expression of phospho-MAPK in non-small cell cancer and its clinicopathological significance

P3-015: Clinicopathologic Features and Epidermal Growth Factor Receptor Mutations Associated with Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer

Clinicopathological and Prognostic Significance of ERα and ERβ Expression in Lung Carcinomas: a Tissue Microarray Study

Expression of ERCC1 in the Patients with Non-Small-cell Lung Cancer

Imbalanced Expression of Mitogen-Activated Protein Kinase Phosphatase-1 and Phosphorylated Extracellular Signal-Regulated Kinases in Lung Squamous Cell Carcinoma

Prognostic values of ERK1/2 and p-ERK1/2 expressions for poor survival in non-small cell lung cancer

Epidermal growth factor receptor (EGFR) mutation and p-EGFR expression in resected non-small cell lung cancer.

Association Between EGFR/KRAS Mutation and Expression of VEGFA, VEGFR and VEGFR2 in Lung Adenocarcinoma

Relationship of Activated Extracellular Signal-Regulated Kinase 1/2 with Lung Metastasis in Salivary Adenoid Cystic Carcinoma.

Expressions of cyclooxygenase-2 and epidermal growth factor receptor in non-small cell lung cancer

Study on expression and significance of epidermal growth factor receptor in 70 cases with non-small cell lung cancer

[Expression of PD-1/PD-L1 in Lung Adenocarcinoma and Correlation with Epidermal Growth Factor Receptor Mutation Status].

Expression and Clinical Significance of the EGFR/STAT Signal Pathway in Idiopathic Pulmonary Fibrosis

[Aberrant Expression of Rb and Prb-780, Prb-795 in Lung Adenocarcinoma Patients with EGFR Mutations and Their Clinical Significance].

High Expression Of Erbb Family Members And Their Ligands In Lung Adenocarcinomas That Are Sensitive To Inhibition Of Epidermal Growth Factor Receptor

KLRB1 expression is associated with lung adenocarcinoma prognosis and immune infiltration and regulates lung adenocarcinoma cell proliferation and metastasis through the MAPK/ERK pathway

ERK 3 Signals Through SRC-3 Coactivator to Promote Human Lung Cancer Cell Invasion

PD-1/PD-L1 expression in non-small-cell lung cancer and its correlation with EGFR/KRAS mutations.

The Role of PKR/eIF2α Signaling Pathway in Prognosis of Non-Small Cell Lung Cancer